Ballerup, Denmark

Esben Paul Krogh Olsen

This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Union Therapeutics A/s. Active years: 2022-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Esben Paul Krogh Olsen. Retrieved from https://idiyas.com/inventor/esben-paul-krogh-olsen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2022-2024

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Esben Paul Krogh Olsen: Innovator in Heterocyclic Compounds

Introduction

Esben Paul Krogh Olsen is a notable inventor based in Ballerup, Denmark. He has made significant contributions to the field of chemistry, particularly in the development of novel methods for the preparation of heterocyclic compounds. With a total of two patents to his name, Olsen's work is recognized for its potential applications in pharmaceutical research.

Latest Patents

Olsen's latest patents focus on methods for the preparation of 1,3-benzodioxole heterocyclic compounds. The first patent describes novel methods for synthesizing these compounds, which are identified as useful PDE4 inhibitors. The second patent reiterates the same focus on 1,3-benzodioxole heterocyclic compounds of formula (I), emphasizing their utility as PDE4 inhibitors as well.

Career Highlights

Olsen is currently associated with Union Therapeutics A/S, where he continues to innovate in the field of medicinal chemistry. His work is pivotal in advancing therapeutic options for various medical conditions.

Collaborations

Olsen collaborates with esteemed colleagues, including Allan Carsten Dahl and Johan Eriksson Bajtner. Their combined expertise enhances the research and development efforts at Union Therapeutics A/S.

Conclusion

Esben Paul Krogh Olsen is a distinguished inventor whose work in heterocyclic compounds holds promise for future pharmaceutical advancements. His contributions are vital to the ongoing research in this important area of chemistry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…